- Home
- RDN vs AXSM Comparison
RDN vs AXSM Comparison
Compare RDN & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDN
- AXSM
- Stock Information
- Founded
- RDN 1977
- AXSM 2012
- Country
- RDN United States
- AXSM United States
- Employees
- RDN N/A
- AXSM N/A
- Industry
- RDN Property-Casualty Insurers
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- RDN Finance
- AXSM Health Care
- Exchange
- RDN Nasdaq
- AXSM Nasdaq
- Market Cap
- RDN 4.5B
- AXSM 5.1B
- IPO Year
- RDN 1992
- AXSM 2015
- Fundamental
- Price
- RDN $35.13
- AXSM $118.42
- Analyst Decision
- RDN Hold
- AXSM Strong Buy
- Analyst Count
- RDN 5
- AXSM 17
- Target Price
- RDN $36.20
- AXSM $175.76
- AVG Volume (30 Days)
- RDN 664.4K
- AXSM 597.5K
- Earning Date
- RDN 11-05-2025
- AXSM 11-11-2025
- Dividend Yield
- RDN 2.90%
- AXSM N/A
- EPS Growth
- RDN 3.12
- AXSM N/A
- EPS
- RDN 3.96
- AXSM N/A
- Revenue
- RDN $1,285,836,000.00
- AXSM $495,033,000.00
- Revenue This Year
- RDN N/A
- AXSM $64.05
- Revenue Next Year
- RDN $2.60
- AXSM $56.46
- P/E Ratio
- RDN $8.88
- AXSM N/A
- Revenue Growth
- RDN 0.32
- AXSM 69.83
- 52 Week Low
- RDN $29.32
- AXSM $75.56
- 52 Week High
- RDN $36.99
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- RDN 53.93
- AXSM 50.90
- Support Level
- RDN $34.60
- AXSM $123.54
- Resistance Level
- RDN $35.60
- AXSM $130.00
- Average True Range (ATR)
- RDN 0.50
- AXSM 3.75
- MACD
- RDN 0.01
- AXSM -0.49
- Stochastic Oscillator
- RDN 54.86
- AXSM 17.34
About RDN Radian Group Inc.
Radian Group Inc is engaged in mortgage and real estate services. It provides both credit-related mortgage insurance coverage and other products and services across the residential real estate and mortgage finance industries. It has one business segment Mortgage Insurance. The Mortgage Insurance segment aggregates, manages, and distributes U.S. mortgage credit risk for the benefit of mortgage lending institutions and mortgage credit investors, through private mortgage insurance on residential first-lien mortgage loans, and also offers other credit risk management solutions, including contract underwriting, to customers. It also provides other mortgage and real estate products and services through Mortgage Conduit, Title, Real Estate Services, and Real Estate Technology businesses.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.